Inactive Instrument

Other languages Genovis AB (publ.) Nasdaq Stockholm

Equities

SE0002485979

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15
Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	03-14
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-15
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	02-15
Genovis to Get $1 Million Milestone Payment for Xork Development	02-13
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Genovis Launch Innovative Igm-Specific Protease with Wide-Ranging Applications in Life Science Markets	02/06/23
Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2023	16/05/23
ArcticZymes Technologies ASA and Genovis AB Announce Collaboration to Speed Up Penetration and Growth in the Chinese Market	03/05/23
Small Caps – Les derniers choix des stars de la gestion	17/02/23
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	15/02/23
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2022	15/02/23
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
Genovis AB Enters Licensing and Supply Agreement with New Bioprocess Customer	10/08/22
Genovis AB Enters Service Agreement with Evitria Ag for Fast LC_MSlysis of Recombinant Antibodies	04/08/22
Genovis AB (Publ.) Announces Board Changes	12/05/22
Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	08/02/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Genovis AB (publ.) Nasdaq Stockholm

Equities

SE0002485979

Other languages

Filters